science

QazCovid-in

QazCovid-in is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand QazCovid-in rather than just read about it. In short: QazCovid-in, commercially known as QazVac, is a COVID-19 vaccine developed by the Research Institute for Biological Safety Problems in Kazakhstan. QazCoVac-P was the second COVID-19 vaccine developed by the Kazakh Biosafety Research Institute and in clinical trials.

Key takeaways

QazCovid-in belongs to science; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect QazCovid-in to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of QazCovid-in from memory before moving on to harder problems.

Reference excerpt

QazCovid-in, commercially known as QazVac, is a COVID-19 vaccine developed by the Research Institute for Biological Safety Problems in Kazakhstan. QazCoVac-P was the second COVID-19 vaccine developed by the Kazakh Biosafety Research Institute and in clinical trials.

Manufacturing The vaccine can be stored at standard refrigeration temperatures (2 °C-8 °C) and is a two-dose régime with the doses administered twenty-one days apart. The vaccine was first manufactured by Kazakhstan's Research Institute of Biological Safety Problems. Production capacity was capped at 50,000 doses per month. The vaccine was slated to be packaged in bulk and be bottled in Turkey by a Turkish company beginning in June 2021. It was intended for a production capacity of 500,000-600,000 doses per month. The contract was still being negotiated as of April 2021, despite earlier claims suggesting that the deal had already been finalized. In October 2021, it was announced that the vaccine would be supplied to Afghanistan and other countries in 2022.

History

Clinical trials In September 2020, QazVac started in Phase I/II clinical trials. In December 2020, QazVac was in Phase III clinical trials, which was expected to be fully completed by 9 July 2021. It is unclear when the first preliminary results will be published. The administration of the vaccine for the general population began at the end of April 2021. The Research Institute Kunsulu Zakarya's Director General's justification is that the trial is almost 50% completed and "people who have received [the] vaccine feel well; there have been no side-effects and the effectiveness of the vaccine is high". In September 2021, a study was published to eClinicalMedicine, published by The Lancet. The study's findings were that the "QazCovid-in® vaccine was safe and well-tolerated and induced predominantly mild adverse events; no serious or severe adverse events were recorded in both trials."

Authorization

Economics The first batch of 50,000 doses was delivered on 26 April 2021, and vaccination began shortly after. In June 2021, the capacity was intended increase to 100,000 doses per month, regardless of the contract for bottling in Turkey.

References

External links

Illustrations

Worked examples

Example 1 — a first encounter with QazCovid-in

Start with the simplest possible case. Write down what QazCovid-in claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to QazCovid-in before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about QazCovid-in ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of QazCovid-in

In research: QazCovid-in appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses QazCovid-in in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: QazCovid-in is common in secondary-school and first-year university syllabi. It links to neighbouring topics Inactivated vaccines, Kazakh COVID-19 vaccines, Science and technology in Kazakhstan, so understanding it makes those chapters shorter.
In everyday life: Look for QazCovid-in outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “QazCovid-in” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study QazCovid-in in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what QazCovid-in means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain QazCovid-in out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is QazCovid-in in simple terms?

Why does QazCovid-in matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study QazCovid-in?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on QazCovid-in.